What You Should Know:
– As healthcare organizations worldwide increasingly prioritize the optimization of their Electronic Health Records (EHRs), a new report from the KLAS Arch Collaborative reveals significant global disparities in clinician satisfaction, with…
Continue Reading
Duane Barnes, President of RapidScale
The cloud is not only a competitive advantage but a new status quo. In fact, the healthcare cloud computing market is expected to grow to $120.6 billion by 2029, up…
Continue Reading
What You Should Know:
– PathAI, a provider of AI-powered pathology solutions, and Northwestern Medicine, Chicago’s premier integrated academic health system announced a strategic multi-year collaboration aimed at transforming pathology diagnostics through the power of…
Continue Reading
Daya management team: Jenny Lundkvist, Jennifer Grönqvist, Malin Frithiofsson, Victorine Lancon. Photo: Elin Tornblad
What You Should Know:
– Daya Ventures, a Swedish venture studio that has rapidly established itself by building femtech companies from scratch,…
Continue Reading
What You Should Know:
– Oxford Cancer Biomarkers Ltd (OCB), a leader in molecular precision cancer diagnostic tests, has today announced a new partnership with Mira Precision Health Inc.
– This collaboration aims to advance OCB’s…
Continue Reading
Brittany Erana, CEO at Jumo Health
What You Should Know:
– Jumo Health, a global leader in optimizing the patient experience in clinical trials announced the appointment of Brittany Erana as its new Chief Executive Officer.
–…
Continue Reading
What You Should Know:
– Vantive, a vital organ therapy company announced a significant global investment plan of more than US $1B over the next five years.
– The investment is earmarked for expanding research and…
Continue Reading
What You Should Know:
– A new analysis from the Urban Institute, supported by the Robert Wood Johnson Foundation, projects that U.S. healthcare providers could lose more than $770B in revenue over the next decade…
Continue Reading
Deb Nevins, Chief Marketing & Strategy Officer at POCN Group
For decades, life sciences companies have centered their marketing efforts on physicians, assuming they hold the greatest influence over prescribing and treatment decisions. However, the…
Continue Reading
What You Should Know:
– Vivodyne, a company pioneering an exclusively human-focused preclinical process, today announced it has raised $40M in new Series A funding led by Khosla Ventures, with participation from new investors Lingotto…
Continue Reading
